11-65182882-T-TC
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_005186.4(CAPN1):c.181_182insC(p.Phe61SerfsTer106) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_005186.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Autosomal recessive spastic paraplegia type 76 Pathogenic:1
The c.181_182insC is not present in publicly available population databases like 1000 Genomes, EVS, Indian Exome Database or our in-house exome database. The heterozygous state of the variant is present in ExAC and gnomAD, at a low frequency. The variant has neither been published in literature nor reported to clinical databases like ClinVar, Human Genome Mutation Database (HGMD) and/or OMIM, in any affected individuals. In silico pathogenicity programs like Mutation Taster, CADD, Varsome etc. predicted this variant to be likely deleterious. The variant causes frameshift at the 61st amino acid position of the original transcript, creating a premature stop signal at the 166th amino acid position of the altered transcript, which may either result in translation of a truncated protein or cause nonsense mediated decay of the mRNA. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.